Cellectar Biosciences, Inc.

Historical 13F Holders

Symbol
CLRB
CUSIP
15117F807
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 15117F807 since 12/18/2024, largest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13G/A
5.7% 2/14/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Lytton Laurence W 13G/A
Amended under CUSIP 15117F880 on 8/14/2025
8.8%
Checked 5% or less
2/13/2025
Event 12/31/2024
Orin Hirschman 13G/A
4.9% 1/27/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 35 5.21 M $1.63 M
2024 Q4 33 5.10 M $1.52 M
2024 Q3 40 14.0 M $30.0 M
2024 Q2 44 13.6 M $33.2 M
2024 Q1 54 9.17 M $36.5 M
2023 Q4 30 9.97 M $27.6 M
2023 Q3 21 1.46 M $3.85 M
2023 Q2 22 1.60 M $3.08 M
2023 Q1 21 1.71 M $2.43 M
2022 Q4 28 1.92 M $3.24 M
2022 Q3 22 637 k $2.14 M
2022 Q2 1 56.0 k $23.0 k